Abrysvo Dosage
Generic name: RECOMBINANT STABILIZED RSV A PREFUSION F ANTIGEN 0.06mg in 0.5mL, RECOMBINANT STABILIZED RSV B PREFUSION F ANTIGEN 0.06mg in 0.5mL;
Dosage form: injection
Drug class: Viral vaccines
Medically reviewed by Drugs.com. Last updated on Mar 28, 2024.
Dose and Schedule
After reconstitution, a single dose of ABRYSVO is either approximately 0.5 mL (vial and prefilled syringe presentation) or 0.5 mL (vial and vial presentation) [see Dosage and Administration (2.2)].
Presentations and Reconstitution
ABRYSVO is supplied in 2 presentations as follows:
Vial and Prefilled Syringe Presentation
The vial and prefilled syringe presentation is supplied in a kit that includes a vial of Lyophilized Antigen Component (a sterile white powder), a prefilled syringe containing the Sterile Water Diluent Component, and a vial adapter.
Vial and Vial Presentation
The vial and vial presentation is supplied in cartons that include vials of Lyophilized Antigen Component (a sterile white powder) and vials containing the Sterile Water Diluent Component.
For both presentations, reconstitute the Lyophilized Antigen Component with the accompanying Sterile Water Diluent Component to form ABRYSVO, as described in the instructions below.
Reconstitution Instructions for Vial and Prefilled Syringe Presentation
Reconstitution Instructions for the Vial and Vial Presentation
Administration
For intramuscular injection
After reconstitution, ABRYSVO is a clear and colorless solution. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Discard if either condition is present.
Administer ABRYSVO immediately or store at room temperature [15°C to 30°C (59°F to 86°F)] and use within 4 hours. Discard reconstituted vaccine if not used within 4 hours.
Frequently asked questions
- What is the difference between Arexvy and Abrysvo?
- What are the symptoms of respiratory syncytial virus (RSV)?
More about Abrysvo (rsv vaccine, pref a-pref b, recombinant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.